352.29
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt WST?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$351.37
Offen:
$349.66
24-Stunden-Volumen:
420.83K
Relative Volume:
0.56
Marktkapitalisierung:
$24.79B
Einnahmen:
$3.22B
Nettoeinkommen (Verlust:
$542.70M
KGV:
47.09
EPS:
7.4805
Netto-Cashflow:
$458.00M
1W Leistung:
+0.36%
1M Leistung:
-0.40%
6M Leistung:
+44.61%
1J Leistung:
+46.85%
West Pharmaceutical Services Inc Stock (WST) Company Profile
Firmenname
West Pharmaceutical Services Inc
Sektor
Telefon
(610) 594-2900
Adresse
530 HERMAN O. WEST DRIVE, EXTON, PA
Compare WST vs ISRG, BDX, ALC, RMD, MDLN
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
WST
West Pharmaceutical Services Inc
|
352.29 | 24.73B | 3.22B | 542.70M | 458.00M | 7.4805 |
|
ISRG
Intuitive Surgical Inc
|
401.27 | 141.75B | 11.03B | 3.16B | 3.22B | 8.7251 |
|
BDX
Becton Dickinson Co
|
183.58 | 49.41B | 21.37B | 1.41B | 3.07B | 3.9437 |
|
ALC
Alcon Inc
|
73.58 | 36.42B | 10.63B | 819.00M | 1.59B | 1.6577 |
|
RMD
Resmed Inc
|
226.00 | 32.61B | 5.54B | 1.52B | 1.74B | 10.37 |
|
MDLN
Medline Inc
|
35.50 | 30.74B | 29.14B | 1.07B | 1.05B | 1.1956 |
West Pharmaceutical Services Inc Stock (WST) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-02 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2025-09-15 | Eingeleitet | Rothschild & Co Redburn | Buy |
| 2025-06-24 | Eingeleitet | Barclays | Equal Weight |
| 2025-03-18 | Eingeleitet | Evercore ISI | Outperform |
| 2025-02-14 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2025-01-08 | Eingeleitet | Citigroup | Buy |
| 2024-12-13 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-12-12 | Hochstufung | UBS | Neutral → Buy |
| 2024-02-07 | Hochstufung | Jefferies | Hold → Buy |
| 2023-06-16 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-04-11 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2022-12-14 | Eingeleitet | Deutsche Bank | Hold |
| 2022-11-30 | Eingeleitet | UBS | Neutral |
| 2022-10-28 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2020-10-14 | Eingeleitet | Stephens | Equal-Weight |
| 2020-07-21 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-04-24 | Hochstufung | BofA/Merrill | Underperform → Neutral |
| 2019-12-12 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2019-07-26 | Hochstufung | BofA/Merrill | Underperform → Neutral |
| 2019-05-01 | Herabstufung | Jefferies | Buy → Hold |
| 2019-04-23 | Eingeleitet | William Blair | Outperform |
| 2018-04-25 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2018-01-24 | Eingeleitet | Goldman | Neutral |
| 2017-10-17 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2017-10-03 | Eingeleitet | Stephens | Equal-Weight |
| 2017-09-15 | Hochstufung | Jefferies | Hold → Buy |
| 2016-10-28 | Hochstufung | Wells Fargo | Market Perform → Outperform |
| 2016-09-21 | Herabstufung | Wells Fargo | Outperform → Market Perform |
| 2016-03-22 | Eingeleitet | Wells Fargo | Outperform |
| 2010-05-14 | Bestätigt | UBS | Neutral |
| 2010-02-23 | Eingeleitet | Jefferies & Co | Buy |
| 2008-12-19 | Eingeleitet | UBS | Neutral |
Alle ansehen
West Pharmaceutical Services Inc Aktie (WST) Neueste Nachrichten
West Pharmaceutical CFO Robert W. McMahon Reports RSU Vesting and Share Withholding Transactions - kalkinemedia.com
West Pharmaceutical (WST) CFO converts RSUs, withholds shares for taxes - Stock Titan
Here's Why You Should Add BrightSpring Stock to Your Portfolio Now - TradingView
Wrapped West Pharmaceutical Services Tokenized Stock (xStock) News - CoinMarketCap
CAH Q4 Earnings Beat on Pharma Strength, Revenues Miss, Stock Up - TradingView
West Pharmaceutical Services, Inc. (WST) options chain - Yahoo Finance UK
West Pharmaceutical Services Inc (WST) Stock Price, Trades & News - GuruFocus
West Pharmaceutical Services, Inc. (WST) Stock Analysis: A 14% Upside Potential with Strong Buy Ratings - DirectorsTalk Interviews
Assenagon Asset Management S.A. Has $23.25 Million Position in West Pharmaceutical Services, Inc. $WST - MarketBeat
ETFs Investing in West Pharmaceutical Services, Inc. Stocks - TradingView
On-body Injector Market Size, Share, Trends, Report, 2026-2035 - gminsights.com
West Pharmaceutical Services, Inc. $WST Position Reduced by Seilern Investment Management Ltd - MarketBeat
Bank of America Corp DE Sells 150,033 Shares of West Pharmaceutical Services, Inc. $WST - MarketBeat
Pharmaceutical-Grade Aluminum Closures Market Outlook to 2035 - IndexBox
West Pharmaceutical Services Inc. stock outperforms competitors on strong trading day - MarketWatch
West Pharmaceutical Services Inc (WST) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
FMR LLC reports 5.0% ownership of West Pharmaceutical (WST) common stock - Stock Titan
Broad-Based Growth Lifted West Pharmaceuticals (WST) in Q2 - finance.yahoo.com
West Pharmaceutical Services declares Q3 2026 distribution of R$ 0.02 per unit - Bitget
Shareholders of West Pharmaceutical Services, Inc. (WST): Protect - The National Law Review
Stronger Q2 Results, Guidance Hike, Buybacks Might Change The Case For Investing In West (WST) - Sahm
Securities Fraud Class Action Filed Against West Pharmaceutical S - The National Law Review
Citi Initiates West Pharmaceutical Services(WST.US) With Buy Rating, Announces Target Price $412 - Moomoo
West Pharmaceutical Services (WST) Stock Analysis: A Potential 18.7% Upside Awaits Investors - DirectorsTalk Interviews
West Pharmaceutical Services, Inc. $WST Stock Position Trimmed by The Manufacturers Life Insurance Company - MarketBeat
Is Stronger Q2 Results, Raised Outlook and Buybacks Altering The Investment Case For West Pharmaceutical Services (WST)? - finance.yahoo.com
The 5 Most Interesting Analyst Questions From West Pharmaceutical Services’s Q2 Earnings Call - finance.yahoo.com
Liontrust Investment Partners LLP Decreases Stake in West Pharmaceutical Services, Inc. $WST - MarketBeat
West Pharmaceutical Services, I (WST) Stock Forecasts - finance.yahoo.com
West Pharmaceutical Services Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
WST Maintains Rating by Evercore ISI Group -- Price Target Raised to $425 - GuruFocus
WEST PHARMACEUTICAL SERVICES INC : EVERCORE ISI RAISES TARGET PRICE TO $425 FROM $410 - Bitget
BNP Paribas Adjusts PT on West Pharmaceutical Services to $459 From $447, Maintains Outperform Rating - marketscreener.com
Weiss Asset Management LP Invests $1.99 Million in West Pharmaceutical Services, Inc. $WST - MarketBeat
Renaissance Technologies LLC Has $52.55 Million Stock Position in West Pharmaceutical Services, Inc. $WST - MarketBeat
West Pharmaceutical stock trades near record levels as injectable packaging demand supports growth - Ad-hoc-news.de
Arrowstreet Capital Limited Partnership Purchases 210,112 Shares of West Pharmaceutical Services, Inc. $WST - MarketBeat
West Pharmaceutical Services, Inc. $WST Shares Acquired by Bank of Nova Scotia - MarketBeat
West Pharmaceutical (WST) Signs Decade Long Daikyo Distribution Deal Beyond Japan - finance.yahoo.com
West Pharmaceutical stock holds recent gains as investors weigh steady growth and guidance - AD HOC NEWS
West Pharmaceutical Services, Inc. (WST) Q1 2024 Earnings ReportResults, Call & Slides - TipRanks
West Pharmaceutical Services, Inc. (WPS) Q4 2022 Earnings ReportResults, Call & Slides - TipRanks
West Pharmaceutical Services, Inc. Revenue Breakdown – MIL:1WST - TradingView
What Does Eric Green's Retirement Mean for West Pharmaceutical Services - Kavout | AI
West Pharmaceutical Services Inc (WST) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
West Pharmaceutical Services, Inc. (WST) Q4 2025 Earnings ReportResults, Call & Slides - TipRanks
West Pharmaceutical stock trades steady as investors digest stronger 2025 guidance and recent margin - AD HOC NEWS
West Pharmaceutical Services, Inc. $WST Shares Sold by KBC Group NV - MarketBeat
Epoch Investment Partners Inc. Acquires 39,745 Shares of West Pharmaceutical Services, Inc. $WST - MarketBeat
Is West Pharmaceutical Services Inc (WST) a Bargain After 7.7% D - GuruFocus
West Pharmaceutical Services (WST) Receives a Buy from Barclays - The Globe and Mail
Finanzdaten der West Pharmaceutical Services Inc-Aktie (WST)
Umsatz
Nettogewinn
Free Cashflow
ENV
West Pharmaceutical Services Inc-Aktie (WST) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Favorite Annette F | Sr. VP & Chief HR Officer |
Apr 27 '26 |
Option Exercise |
83.47 |
2,817 |
235,135 |
19,645 |
| Favorite Annette F | Sr. VP & Chief HR Officer |
Apr 27 '26 |
Sale |
305.20 |
2,817 |
859,753 |
16,828 |
| Winters Chad | VP, Chief Accounting Officer |
Apr 27 '26 |
Option Exercise |
173.22 |
896 |
155,205 |
2,419 |
| Winters Chad | VP, Chief Accounting Officer |
Apr 27 '26 |
Sale |
300.67 |
896 |
269,399 |
1,523 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):